Expression of ADAMTS-1, -4, -5 and TIMP-3 in normal and multiple sclerosis CNS white matter

G Haddock1, A K Cross, J Plumb

  • 1Biomedical Research Centre, Sheffield Hallam University, Howard Street, Sheffield S1 1WB, UK. g.haddock@shu.ac.uk

Multiple Sclerosis (Houndmills, Basingstoke, England)
|August 12, 2006
PubMed

Insights

Researchers found increased levels of ADAMTS-4 protein in multiple sclerosis (MS) brain tissue, suggesting this enzyme may contribute to MS pathogenesis by affecting the central nervous system extracellular matrix.

Area of Science:

  • Neuroscience
  • Biochemistry
  • Pathology

Background:

  • ADAMTS proteases degrade chondroitin sulphate proteoglycans (CSPGs) in the central nervous system (CNS).
  • CSPGs are key components of the CNS extracellular matrix (ECM).
  • ECM changes are implicated in the pathogenesis of multiple sclerosis (MS).

Purpose of the Study:

  • To investigate the expression of ADAMTS-1, -4, -5, and TIMP-3 in normal and MS CNS white matter.
  • To determine the role of these proteins in the pathogenesis of MS.

Main Methods:

  • Real-time RT-PCR to quantify mRNA levels.
  • Western blotting to assess protein levels.
  • Immunohistochemistry to localize protein expression in CNS tissue.

Main Results:

  • ADAMTS-1 and -5 mRNA levels were decreased in MS white matter compared to normal tissue.
  • ADAMTS-4 mRNA levels showed no significant change, but protein levels were significantly higher in MS tissue.
  • ADAMTS-4 was predominantly associated with astrocytes and showed increased expression in MS lesions.
  • TIMP-3 mRNA levels were significantly decreased in MS tissue.

Conclusions:

  • ADAMTS-4 expression is altered in MS, with increased protein levels in affected white matter.
  • The findings suggest a potential role for ADAMTS-4 in the pathogenesis of MS.
  • Further research into ADAMTS-4 activity is needed to understand its role in white matter ECM turnover in MS.